Magda Marquet Buys Shares of TRAX $TRAX
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Magda Marquet, insider at First Tracks Biotherapeutics, Inc. ($TRAX), bought 6,030 shares at an average price of $0. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
First Tracks Biotherapeutics, Inc. Stock Down 56.6%
Shares of First Tracks Biotherapeutics, Inc. ($TRAX) traded around $18.17 on Wednesday, down 56.6% for the day.
First Tracks Biotherapeutics, Inc. Earnings
Analysts Set New Price Targets
About First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. Its products includes ANB033, a novel anti-CD122 antagonist that targets the shared beta subunit of the IL-15 and IL-2 receptors; Rosnilimab, a antibody engineered to selectively deplete pathogenic T cells in both the periphery and inflamed tissues; and ANB101, a BDCA2-modulating antibody designed to specifically target plasmacytoid dendritic cells (pDCs). First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was founded in 2019 and is based in San Diego, California.
Get First Tracks Biotherapeutics, Inc. alerts
New 13F filings, insider trades, and analyst moves on $TRAX, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.